Cancer News and Research

Latest Cancer News and Research

Researchers give new, unprecedented 3-D view of most important brain receptors

Researchers with Oregon Health & Science University's Vollum Institute have given science a new and unprecedented 3-D view of one of the most important receptors in the brain - a receptor that allows us to learn and remember, and whose dysfunction is involved in a wide range of neurological diseases and conditions, including Alzheimer's, Parkinson's, schizophrenia and depression.

28 Jun 2014

Researchers identify two classes of anti-depressants that reduce symptoms of depression

Depression is common in cancer, up to half of all patients facing the disease experience depressive symptoms, ranging from mild to severe. When depression co-exists with cancer, patients may be at an increased risk of death from cancer and from suicide.

28 Jun 2014

European approval process for Eckert & Ziegler’s gallium-68 generator is successfully completed

Eckert & Ziegler Radiopharma GmbH has received a recommendation from the European Medicines Agency for approval of its pharmaceutical 68Ge/68Ga generators.

28 Jun 2014

Some cancer patients with aggressive tumors may benefit from anti-inflammatory drugs

New research raises the prospect that some cancer patients with aggressive tumors may benefit from a class of anti-inflammatory drugs used to treat rheumatoid arthritis.

28 Jun 2014

Researchers find way to diagnose aggressiveness of oral cancer

Studying mouth cancer in mice, researchers have found a way to predict the aggressiveness of similar tumors in people, an early step toward a diagnostic test that could guide treatment, according to researchers at Washington University School of Medicine in St. Louis.

28 Jun 2014

Janssen seeks expanded approval of VELCADE from EU for Mantle Cell Lymphoma

Janssen-Cilag International NV today announced its submission of a type II variation to the European Medicines Agency to expand the label for VELCADE (bortezomib) to include its use, in combination with rituximab, cyclophosphamide, doxorubicin and prednisone, for the treatment of adult patients with previously untreated Mantle Cell Lymphoma (MCL).

28 Jun 2014

Study identifies genetics as dominant risk factor in breast, prostate and colorectal cancers

A study of individuals who have been adopted has identified genetics as the dominant risk factor in 'familial' breast, prostate and colorectal cancers.

27 Jun 2014

Alaska to be hit hard with hospital infection penalties

Elsewhere, medical marijuana's usefulness in treating pain is questioned after New York lawmakers legalized it.

27 Jun 2014

Research shows colon cancer survivors are more likely to experience pain in back, abdomen

Researchers from the University of Granada have discovered that colon cancer survivors are more likely to suffer future lesions related with pain in the back and lower abdomen than healthy individuals of the same gender and age.

27 Jun 2014

Research roundup: Role of primary care in reducing readmissions; air transport for wounded soldiers; hospital prices

Follow-up with a primary care provider (PCP) in addition to the surgical team is routinely recommended to patients discharged after major surgery despite no clear evidence that it improves outcomes.

27 Jun 2014

Non-Hodgkin lymphoma subgroups found to have different survival rates

A Mayo Clinic-led group of researchers has discovered three subgroups of a single type of non-Hodgkin lymphoma that have markedly different survival rates. These subgroups could not be differentiated by routine pathology but only with the aid of novel genetic tests, which the research team recommends giving to all patients with ALK-negative anaplastic large-cell lymphoma (ALCL). Findings are published in the journal Blood.

27 Jun 2014

First Edition: June 27, 2014

Today's early morning highlights from the major news organizations, including reports on an HHS announcement detailing some of the marketplace enrollment plans for next fall.

27 Jun 2014

Researchers perform systematic review to identify best treatments for cancer-related depression

27 Jun 2014

HOC pleads guilty for selling misbranded, unapproved chemotherapy drugs

Hematology and Oncology Center (HOC) PLLC of Somerset, Kentucky has pleaded guilty to federal charges that the firm purchased and sold unapproved and improperly labeled chemotherapy drugs.

27 Jun 2014

Cancer drug shows promise in treating blood cell disorders

Scientists working to make gene therapy a reality have solved a major hurdle: how to bypass a blood stem cell's natural defenses and efficiently insert disease-fighting genes into the cell's genome.

27 Jun 2014

Interactions with other infections can trigger herpes virus to reactivate, shows research

The famous slogan is "A diamond is forever," but that phrase might be better suited to herpes: Unlike most viruses, which succumb to the immune system's attack, herpes remains in the body forever, lying in wait, sometimes reactivating years later.

27 Jun 2014

Web search trends increase during Autism Awareness Month

Autism Awareness Month each April brings blue lights and puzzle shapes out to shine in many communities - but does it actually lead to increased autism awareness? According to a new analysis of web search trends by researchers at Drexel University, it does appear to drive an increase in Google searches for autism - by a third over searches in March in recent years.

27 Jun 2014

ONCOblot test identifies ENOX2 cancer marker, paves way for minimally invasive tests

Cancer is rarely black and white, and it's no small matter no matter how small, but a new discovery in the field of cancer screenings has come to light that signals a shift to an earlier, more certain and specific cancer diagnosis.

27 Jun 2014

New 3D mammography helps diagnose breast cancer quickly than ever before

Screening for and diagnosing breast cancer is quicker and more precise than ever before thanks to new three-dimensional (3D) mammography being used at the Herman & Walter Samuelson Breast Care Center at Northwest.

27 Jun 2014

Surgical biopsies can be safely performed on selected patients with late-stage lung cancer

Researchers at UC Davis have determined that surgical biopsies can be safely performed on select patients with late-stage non-small cell lung cancer, which should enhance their access to drugs that target specific genetic mutations such as epidermal growth factor receptor (EGFR).

27 Jun 2014

Cancer News and Research

Latest Cancer News and Research

Researchers give new, unprecedented 3-D view of most important brain receptors

Researchers identify two classes of anti-depressants that reduce symptoms of depression

European approval process for Eckert & Ziegler’s gallium-68 generator is successfully completed

Some cancer patients with aggressive tumors may benefit from anti-inflammatory drugs

Researchers find way to diagnose aggressiveness of oral cancer

Janssen seeks expanded approval of VELCADE from EU for Mantle Cell Lymphoma

Study identifies genetics as dominant risk factor in breast, prostate and colorectal cancers

Alaska to be hit hard with hospital infection penalties

Research shows colon cancer survivors are more likely to experience pain in back, abdomen

Research roundup: Role of primary care in reducing readmissions; air transport for wounded soldiers; hospital prices

Non-Hodgkin lymphoma subgroups found to have different survival rates

First Edition: June 27, 2014

Researchers perform systematic review to identify best treatments for cancer-related depression

HOC pleads guilty for selling misbranded, unapproved chemotherapy drugs

Cancer drug shows promise in treating blood cell disorders

Interactions with other infections can trigger herpes virus to reactivate, shows research

Web search trends increase during Autism Awareness Month

ONCOblot test identifies ENOX2 cancer marker, paves way for minimally invasive tests

New 3D mammography helps diagnose breast cancer quickly than ever before

Surgical biopsies can be safely performed on selected patients with late-stage lung cancer

Understanding the DNA Damage Response in Innate Immunity eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Cancer News and Research

Latest Cancer News and Research

Understanding the DNA Damage Response in Innate Immunity eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Newsletters you may be interested in